Stay updated on PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. This appears to be a minor version change with no visible impact on study details or user interactions.SummaryDifference0.0%

- Check3 days agoChange DetectedRevision: v3.4.1 was applied, replacing v3.4.0; no other content changes are observed.SummaryDifference0.0%

- Check11 days agoChange DetectedThe additions and deletions are minor UI changes (Show glossary) and capitalization/wording tweaks (Last Update Submitted that Met QC Criteria vs met QC Criteria; No FEAR Act Data vs data; Revision: v3.4.0) that do not modify core study information or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe Update timestamp label changed from 'Last Update Posted (Estimated)' to 'Last Update Posted' on the page. This is a minor labeling update that does not alter core study content or decisions.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, indicating a minor update to the site metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded two new sites in Salt Lake City (University of Utah Hospital and Primary Children's Hospital), bringing the total number of study locations to 53.SummaryDifference0.3%

Stay in the know with updates to PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.